Fortrea Holdings, Inc. (FTRE)
18.36
+0.64
(+3.61%)
USD |
NASDAQ |
Sep 02, 16:00
18.36
0.00 (0.00%)
After-Hours: 20:00
Fortrea Holdings Cash from Investing (Quarterly) : -7.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.00M |
| March 31, 2026 | -8.00M |
| December 31, 2025 | -7.50M |
| September 30, 2025 | 13.30M |
| June 30, 2025 | -7.50M |
| March 31, 2025 | 16.10M |
| December 31, 2024 | 3.50M |
| September 30, 2024 | -8.10M |
| June 30, 2024 | 265.40M |
| Date | Value |
|---|---|
| March 31, 2024 | -9.20M |
| December 31, 2023 | -9.00M |
| September 30, 2023 | 2.70M |
| June 30, 2023 | -9.30M |
| March 31, 2023 | -16.20M |
| December 31, 2022 | -18.40M |
| September 30, 2022 | -16.90M |
| June 30, 2022 | -7.60M |
| March 31, 2022 | -11.10M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Charles River Laboratories International, Inc. | 28.10M |
| IQVIA Holdings, Inc. | -381.00M |
| Medpace Holdings, Inc. | -23.88M |
| Personalis, Inc. | 38.16M |
| 10X Genomics, Inc. | -7.735M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 28.90M |
| Free Cash Flow | 196.00M |
| Free Cash Flow Per Share (Quarterly) | 0.2099 |
| Free Cash Flow to Equity (Quarterly) | 20.40M |
| Free Cash Flow to Firm (Quarterly) | 234.40M |
| Free Cash Flow Yield | 11.47% |